IGM BIOSCIENCES INC (IGMS)

US4495851085 - Common Stock

6.82  +0.07 (+1.04%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
1.07M2.13M
99.07%		3.097M
45.40%
EBITDA
YoY % growth
-160.84M
-95.55%		-221.88M
-37.95%		-255.184M
-15.01%		-215.478M
15.56%		N/AN/AN/AN/A
EBIT
YoY % growth
-165.32M
-98.51%		-227.96M
-37.89%		-263.461M
-15.57%		-216.514M
17.82%
Operating Margin
N/A-21,304.67%-12,369.06%-6,991.10%
EPS
YoY % growth
-4.93
-86.04%		-5.37
-8.92%		-4.81
10.43%		-3.28
31.86%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.85
36.24%
Revenue
Q2Q % growth		774.568K
48.96%
EBITDA
Q2Q % growth		-55.554MN/AN/AN/AN/A
EBIT
Q2Q % growth		-54.765M
13.58%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -1.01
15.13%		-1.050.044.11%
Q3 2023
Q2Q % growth		 -1.04
21.21%		-1.240.2015.94%
Q2 2023
Q2Q % growth		 -1.43
-7.52%		-1.460.032.23%
Q1 2023
Q2Q % growth		 -1.33
13.07%		-1.390.064.39%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 651K
75.95%		716.173K-65.173K-9.10%
Q3 2023
Q2Q % growth		 510K
54.55%		829.036K-319.036K-38.48%
Q2 2023
Q2Q % growth		 450K
21.62%		813.552K-363.552K-44.69%
Q1 2023
Q2Q % growth		 520K
∞%		1.677M-1.157M-68.99%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 15.38% 15.01% 27.7%
Revenue0% -70.65% -69.55% -68.86%